Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

Clinical trial NCT07247266 · RECRUITING

Trial details

NCT number: NCT07247266
Sponsor: Akros Pharma Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cryopyrin-associated Periodic Syndromes (CAPS)

Start date: 2026-02-02
Primary completion: 2026-06-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.